期刊文献+

枯草溶菌素转换酶9在大鼠心肌缺血再灌注损伤中的表达变化 被引量:2

Expression of proproteinconvertase subtilisin/kexin type 9 in myocardial ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的:研究枯草溶菌素转换酶9(proproteinconvertase subtilisin/kexin type 9,PCSK9)在大鼠心肌缺血再灌注损伤中的表达变化。方法:采用大鼠心肌缺血再灌注损伤模型,大鼠分4组:对照组(n=5)、实验组分别为缺血45 min再灌注6 h、12 h及24 h组(各组n=5)。实验终点时,收集血液及缺血区心肌组织,全自动生化分析仪测定心肌酶谱(CK、CK-MB和LDH),HE染色观察心肌组织病理学改变,分别采用实时定量PCR及Western blot方法检测心肌PCSK9 mRNA及蛋白水平表达的改变。结果:与对照组相比,实验组CK、CK-MB和LDH在6 h和12 h组均明显升高有统计学意义,24 h组恢复正常;HE染色发现心肌组织病理损伤随着再灌注时间延长而加重;实验各组心肌PCSK9 mRNA及蛋白水平表达均显著高于对照组,并且随着再灌注时间的延长表达水平逐渐增高。结论:PCSK9可能参与心肌缺血再灌注损伤的病理生理过程。 Objective:To investigate the expression of proproteinconvertase subtilisin/kexin type 9(PCSK9) in the rats myocardium impaired by ischemia-reperfusion.Methods:The left descending coronary artery(LAD) of rats was occluded for 45 min,followed by reperfusion of 6,12,or 24 h,respectively.The levels of creatine kinase(CK),creatine kinase MB(CK-MB) and lactate dehydrogenase(LDH) in serum were measured by automatic biochemical analyzer.The pathological changes in myocardium of rat were examined by HE staining.The expression of PCSK9 in myocardium was detected by RT-PCR and Western blot.Results:The levels of CK,CK-MB and LDH were significantly increased after 6 h and 12 h of reperfusion,and restored to normal level after 24 h of reperfusion.The reperfusion-induced myocardial damage increased in a time-dependent manner.The expression of PCSK9 mRNA and protein were significantly and time-depentently increased by ischemia-reperfusion injury.Conclusion:PCSK9 may be invovled in the myocardial ischemia-reperfusion injury.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第3期380-383,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 湖南省应用基础研究计划重点项目(2008FJ2006) 湖南省科技厅计划项目(2009TP4057-2) 湖南省教育厅重点科研项目(10A105) 湖南省高校科技创新团队支持计划资助
关键词 心肌缺血再灌注损伤 枯草溶菌素转换酶9 表达 myocardial ~sehenna-reperluslon injury PIG3K9 expression
  • 相关文献

参考文献14

  • 1Peterson AS, Fong LG, Young SG. PCSK9 function and physiology[J]. J Lipid Res, 2008, 49(7) : 1595-1599.
  • 2Mousavi SA, Berge KE, Leren TP. The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis[J]. J Intern Med,2009,266(6):507-519.
  • 3于严,汤健,王东炎,苏静怡,唐朝枢.牛磺酸对大鼠异丙肾上腺素心肌损伤的保护作用[J].中国病理生理杂志,1991,7(6):566-568. 被引量:57
  • 4Seidah NG, Benjannet S, Wickham L, et al. The secretory proprotein convertase neural apoptosis -regulated convertase 1 (NARC-I): liver regeneration and neuronal differentiation [J]. Proc Natl Acad Sci USA, 2003, 100 (3)-928-933.
  • 5Duff C J, Hooper NM. PCSK9: an emerging target for treatment of hypercholesterolemia [J]. Expert Opin Ther Targets,2011, 15(2) : 157-168.
  • 6Akram ON, Bernier A, Petrides F, et al. Beyond LDL cholesterol, a new role for PCSK9 [J].Arterioscler Thromb Vasc Biol, 2010, 30(7) : 1279-1281.
  • 7Costet P, Cariou B, Lambert G, et al. Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein lc [J]. J Biol Chem,2006,281 (10) :6211-6218.
  • 8Dubuc G, Tremblay M, Pare G, et al. A new method for measurement of total plasma PCSK9 : clinical applications [J]. J Lipid Res, 2010,51 (1) : 140-149.
  • 9Lakoski SG, Lagace TA, Cohen JC, et al. Genetic and metabolic determinants of plasma PCSK9 levels [J]. J Clin Endocrinol Metab, 2009,94(7) : 2537-2543.
  • 10Feingold KR, Moser AH, Shigenaga JK, et al. Inflammation stimulates the expression of PCSK9 [J]. Biochem Biophys Res Commun, 2008,374(2) : 341-344.

二级参考文献18

  • 1程艳丽,谢闵,刘录山,王贵学.pcsk9基因突变与胆固醇血症[J].中国生物化学与分子生物学报,2007,23(3):172-176. 被引量:6
  • 2Elagoz A, Benjannel S, Mammarbassi A, et al. Biosynthesis and cellular trafficking of the convertase SKI-1/SIP: eetodomain shedding requires SKI-1activity. J Biol Chem, 2002, 277 (13): 11265- 11275
  • 3Seidah N G, Benjannet S, Wickham L, et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.Proc Natl Acad Sci USA, 2003, 100(3): 928-933
  • 4Maxwell K N, Fisher E A, Breslow J L, et al. Over expression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci USA, 2005, 102(6): 2069-2074
  • 5Poirier S, Prat A, Marcinkiewicz E, et al. Implication of the proprotein convertase PCSK9/NARC-1 in the development of the nervous system. J Neurochem, 2006, 98(3): 838-850
  • 6Peterson A S, Fong L G, Young S G. PCSK9 function and physiology. J Lipid Res, 2008, 49(6): 1152- 1156
  • 7Bingham B, Shen R, Kotnis S, et al. Proapoptotic effects ofNARC 1 (= PCSKg), the gene encoding a novel serine proteinase. Cytometry A, 2006, 69(11): 1123-1131
  • 8Brown M S, Goldstein J L. Lowing LDL-not only how low, but how long?. Science, 2006, 311(5768): 1721 - 1723
  • 9Libby P, Geng Y J, Aikawa M, et al. Macrophage and atherosclerotic plaque stability. Curr Opin Lipidol, 1996, 7(5): 330-335
  • 10Boyle J J. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture, Curr Vasc Pharmacol, 2005, 3 (1): 63-68

共引文献77

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部